Global Dendritic Cell Cancer Vaccine Market Growth 2021-2026
According to this latest study, the 2020 growth of Dendritic Cell Cancer Vaccine will have significant change from previous year. By the most conservative estimates of global Dendritic Cell Cancer Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Dendritic Cell Cancer Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Dendritic Cell Cancer Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
CreaVax
Sipuleucel-T (Provenge)
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Pediatrics
Adults
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Medigene
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower (Dendreon)
Elios Therapeutics
Immunicum
Kiromic
Merck
Northwest Biotherapeutics
Glaxo Smith Kline
ImmunoCellular
Tella
Vaxil Bio
Medigene
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dendritic Cell Cancer Vaccine Consumption 2016-2026
2.1.2 Dendritic Cell Cancer Vaccine Consumption CAGR by Region
2.2 Dendritic Cell Cancer Vaccine Segment by Type
2.2.1 CreaVax
2.2.2 Sipuleucel-T (Provenge)
2.2.3 Others
2.3 Dendritic Cell Cancer Vaccine Sales by Type
2.3.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Dendritic Cell Cancer Vaccine Sale Price by Type (2016-2021)
2.4 Dendritic Cell Cancer Vaccine Segment by Application
2.4.1 Pediatrics
2.4.2 Adults
2.5 Dendritic Cell Cancer Vaccine Sales by Application
2.5.1 Global Dendritic Cell Cancer Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Dendritic Cell Cancer Vaccine Sale Price by Application (2016-2021)
3 Global Dendritic Cell Cancer Vaccine by Company
3.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Company
3.1.1 Global Dendritic Cell Cancer Vaccine Sales by Company (2019-2021)
3.1.2 Global Dendritic Cell Cancer Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Company
3.2.1 Global Dendritic Cell Cancer Vaccine Revenue by Company (2019-2021)
3.2.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Dendritic Cell Cancer Vaccine Sale Price by Company
3.4 Global Manufacturers Dendritic Cell Cancer Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dendritic Cell Cancer Vaccine Product Location Distribution
3.4.2 Players Dendritic Cell Cancer Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dendritic Cell Cancer Vaccine by Region
4.1 Global Dendritic Cell Cancer Vaccine by Region
4.1.1 Global Dendritic Cell Cancer Vaccine Sales by Region
4.1.2 Global Dendritic Cell Cancer Vaccine Revenue by Region
4.2 Americas Dendritic Cell Cancer Vaccine Sales Growth
4.3 APAC Dendritic Cell Cancer Vaccine Sales Growth
4.4 Europe Dendritic Cell Cancer Vaccine Sales Growth
4.5 Middle East & Africa Dendritic Cell Cancer Vaccine Sales Growth
5 Americas
5.1 Americas Dendritic Cell Cancer Vaccine Sales by Country
5.1.1 Americas Dendritic Cell Cancer Vaccine Sales by Country (2016-2021)
5.1.2 Americas Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021)
5.2 Americas Dendritic Cell Cancer Vaccine Sales by Type
5.3 Americas Dendritic Cell Cancer Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dendritic Cell Cancer Vaccine Sales by Region
6.1.1 APAC Dendritic Cell Cancer Vaccine Sales by Region (2016-2021)
6.1.2 APAC Dendritic Cell Cancer Vaccine Revenue by Region (2016-2021)
6.2 APAC Dendritic Cell Cancer Vaccine Sales by Type
6.3 APAC Dendritic Cell Cancer Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dendritic Cell Cancer Vaccine by Country
7.1.1 Europe Dendritic Cell Cancer Vaccine Sales by Country (2016-2021)
7.1.2 Europe Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021)
7.2 Europe Dendritic Cell Cancer Vaccine Sales by Type
7.3 Europe Dendritic Cell Cancer Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dendritic Cell Cancer Vaccine by Country
8.1.1 Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Type
8.3 Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dendritic Cell Cancer Vaccine Distributors
10.3 Dendritic Cell Cancer Vaccine Customer
11 Global Dendritic Cell Cancer Vaccine Market Forecast
11.1 Global Dendritic Cell Cancer Vaccine Forecast by Region
11.1.1 Global Dendritic Cell Cancer Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Dendritic Cell Cancer Vaccine Forecast by Type
11.7 Global Dendritic Cell Cancer Vaccine Forecast by Application
12 Key Players Analysis
12.1 Medigene
12.1.1 Medigene Medigene Company Information
12.1.2 Medigene Dendritic Cell Cancer Vaccine Product Offered
12.1.3 Medigene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Medigene Main Business Overview
12.1.5 Medigene Latest Developments
12.2 Activarti
12.2.1 Activarti Company Information
12.2.2 Activarti Dendritic Cell Cancer Vaccine Product Offered
12.2.3 Activarti Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Activarti Main Business Overview
12.2.5 Activarti Latest Developments
12.3 Argos Therapeutics
12.3.1 Argos Therapeutics Company Information
12.3.2 Argos Therapeutics Dendritic Cell Cancer Vaccine Product Offered
12.3.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Argos Therapeutics Main Business Overview
12.3.5 Argos Therapeutics Latest Developments
12.4 Batavia Bioservices
12.4.1 Batavia Bioservices Company Information
12.4.2 Batavia Bioservices Dendritic Cell Cancer Vaccine Product Offered
12.4.3 Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Batavia Bioservices Main Business Overview
12.4.5 Batavia Bioservices Latest Developments
12.5 Bellicum Pharmaceuticals
12.5.1 Bellicum Pharmaceuticals Company Information
12.5.2 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Offered
12.5.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Bellicum Pharmaceuticals Main Business Overview
12.5.5 Bellicum Pharmaceuticals Latest Developments
12.6 Creagene
12.6.1 Creagene Company Information
12.6.2 Creagene Dendritic Cell Cancer Vaccine Product Offered
12.6.3 Creagene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Creagene Main Business Overview
12.6.5 Creagene Latest Developments
12.7 DanDrit Biotech
12.7.1 DanDrit Biotech Company Information
12.7.2 DanDrit Biotech Dendritic Cell Cancer Vaccine Product Offered
12.7.3 DanDrit Biotech Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 DanDrit Biotech Main Business Overview
12.7.5 DanDrit Biotech Latest Developments
12.8 DCPrime
12.8.1 DCPrime Company Information
12.8.2 DCPrime Dendritic Cell Cancer Vaccine Product Offered
12.8.3 DCPrime Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 DCPrime Main Business Overview
12.8.5 DCPrime Latest Developments
12.9 Sanpower (Dendreon)
12.9.1 Sanpower (Dendreon) Company Information
12.9.2 Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Product Offered
12.9.3 Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Sanpower (Dendreon) Main Business Overview
12.9.5 Sanpower (Dendreon) Latest Developments
12.10 Elios Therapeutics
12.10.1 Elios Therapeutics Company Information
12.10.2 Elios Therapeutics Dendritic Cell Cancer Vaccine Product Offered
12.10.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Elios Therapeutics Main Business Overview
12.10.5 Elios Therapeutics Latest Developments
12.11 Immunicum
12.11.1 Immunicum Company Information
12.11.2 Immunicum Dendritic Cell Cancer Vaccine Product Offered
12.11.3 Immunicum Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Immunicum Main Business Overview
12.11.5 Immunicum Latest Developments
12.12 Kiromic
12.12.1 Kiromic Company Information
12.12.2 Kiromic Dendritic Cell Cancer Vaccine Product Offered
12.12.3 Kiromic Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Kiromic Main Business Overview
12.12.5 Kiromic Latest Developments
12.13 Merck
12.13.1 Merck Company Information
12.13.2 Merck Dendritic Cell Cancer Vaccine Product Offered
12.13.3 Merck Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Merck Main Business Overview
12.13.5 Merck Latest Developments
12.14 Northwest Biotherapeutics
12.14.1 Northwest Biotherapeutics Company Information
12.14.2 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Offered
12.14.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Northwest Biotherapeutics Main Business Overview
12.14.5 Northwest Biotherapeutics Latest Developments
12.15 Glaxo Smith Kline
12.15.1 Glaxo Smith Kline Company Information
12.15.2 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Product Offered
12.15.3 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Glaxo Smith Kline Main Business Overview
12.15.5 Glaxo Smith Kline Latest Developments
12.16 ImmunoCellular
12.16.1 ImmunoCellular Company Information
12.16.2 ImmunoCellular Dendritic Cell Cancer Vaccine Product Offered
12.16.3 ImmunoCellular Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 ImmunoCellular Main Business Overview
12.16.5 ImmunoCellular Latest Developments
12.17 Tella
12.17.1 Tella Company Information
12.17.2 Tella Dendritic Cell Cancer Vaccine Product Offered
12.17.3 Tella Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Tella Main Business Overview
12.17.5 Tella Latest Developments
12.18 Vaxil Bio
12.18.1 Vaxil Bio Company Information
12.18.2 Vaxil Bio Dendritic Cell Cancer Vaccine Product Offered
12.18.3 Vaxil Bio Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Vaxil Bio Main Business Overview
12.18.5 Vaxil Bio Latest Developments
12.19 Medigene
12.19.1 Medigene Company Information
12.19.2 Medigene Dendritic Cell Cancer Vaccine Product Offered
12.19.3 Medigene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Medigene Main Business Overview
12.19.5 Medigene Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Dendritic Cell Cancer Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of CreaVax
Table 3. Major Players of Sipuleucel-T (Provenge)
Table 4. Major Players of Others
Table 5. Global Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)
Table 6. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Table 7. Global Dendritic Cell Cancer Vaccine Revenue by Type (2016-2021) & ($ million)
Table 8. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2016-2021)
Table 9. Global Dendritic Cell Cancer Vaccine Sale Price by Type (2016-2021)
Table 10. Global Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)
Table 11. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Table 12. Global Dendritic Cell Cancer Vaccine Value by Application (2016-2021)
Table 13. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2016-2021)
Table 14. Global Dendritic Cell Cancer Vaccine Sale Price by Application (2016-2021)
Table 15. Global Dendritic Cell Cancer Vaccine Sales by Company (2019-2021) & (K Doses)
Table 16. Global Dendritic Cell Cancer Vaccine Sales Market Share by Company (2019-2021)
Table 17. Global Dendritic Cell Cancer Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Company (2019-2021)
Table 19. Global Dendritic Cell Cancer Vaccine Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Dendritic Cell Cancer Vaccine Producing Area Distribution and Sales Area
Table 21. Players Dendritic Cell Cancer Vaccine Products Offered
Table 22. Dendritic Cell Cancer Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Dendritic Cell Cancer Vaccine Sales by Region (2016-2021) (K Doses)
Table 26. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2016-2021)
Table 27. Global Dendritic Cell Cancer Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2016-2021)
Table 29. Americas Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)
Table 30. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)
Table 31. Americas Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)
Table 33. Americas Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)
Table 34. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Table 35. Americas Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)
Table 36. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Table 37. APAC Dendritic Cell Cancer Vaccine Sales by Region (2016-2021) & (K Doses)
Table 38. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Region (2016-2021)
Table 39. APAC Dendritic Cell Cancer Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2016-2021)
Table 41. APAC Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)
Table 42. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Table 43. APAC Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)
Table 44. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Table 45. Europe Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)
Table 46. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)
Table 47. Europe Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)
Table 49. Europe Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)
Table 50. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Table 51. Europe Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)
Table 52. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)
Table 54. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)
Table 58. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)
Table 60. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Table 61. Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2021-2026) & (K Doses)
Table 62. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2021-2026) & (K Doses)
Table 66. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 69. Medigene Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 70. Medigene Dendritic Cell Cancer Vaccine Product Offered
Table 71. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 72. Medigene Main Business
Table 73. Medigene Latest Developments
Table 74. Activarti Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 75. Activarti Dendritic Cell Cancer Vaccine Product Offered
Table 76. Activarti Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 77. Activarti Main Business
Table 78. Activarti Latest Developments
Table 79. Argos Therapeutics Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Argos Therapeutics Dendritic Cell Cancer Vaccine Product Offered
Table 81. Argos Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 82. Argos Therapeutics Main Business
Table 83. Argos Therapeutics Latest Developments
Table 84. Batavia Bioservices Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Batavia Bioservices Dendritic Cell Cancer Vaccine Product Offered
Table 86. Batavia Bioservices Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 87. Batavia Bioservices Main Business
Table 88. Batavia Bioservices Latest Developments
Table 89. Bellicum Pharmaceuticals Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Offered
Table 91. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 92. Bellicum Pharmaceuticals Main Business
Table 93. Bellicum Pharmaceuticals Latest Developments
Table 94. Creagene Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Creagene Dendritic Cell Cancer Vaccine Product Offered
Table 96. Creagene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 97. Creagene Main Business
Table 98. Creagene Latest Developments
Table 99. DanDrit Biotech Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. DanDrit Biotech Dendritic Cell Cancer Vaccine Product Offered
Table 101. DanDrit Biotech Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 102. DanDrit Biotech Main Business
Table 103. DanDrit Biotech Latest Developments
Table 104. DCPrime Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. DCPrime Dendritic Cell Cancer Vaccine Product Offered
Table 106. DCPrime Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 107. DCPrime Main Business
Table 108. DCPrime Latest Developments
Table 109. Sanpower (Dendreon) Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Product Offered
Table 111. Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 112. Sanpower (Dendreon) Main Business
Table 113. Sanpower (Dendreon) Latest Developments
Table 114. Elios Therapeutics Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Elios Therapeutics Dendritic Cell Cancer Vaccine Product Offered
Table 116. Elios Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 117. Elios Therapeutics Main Business
Table 118. Elios Therapeutics Latest Developments
Table 119. Immunicum Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. Immunicum Dendritic Cell Cancer Vaccine Product Offered
Table 121. Immunicum Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 122. Immunicum Main Business
Table 123. Immunicum Latest Developments
Table 124. Kiromic Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. Kiromic Dendritic Cell Cancer Vaccine Product Offered
Table 126. Kiromic Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 127. Kiromic Main Business
Table 128. Kiromic Latest Developments
Table 129. Merck Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Merck Dendritic Cell Cancer Vaccine Product Offered
Table 131. Merck Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 132. Merck Main Business
Table 133. Merck Latest Developments
Table 134. Northwest Biotherapeutics Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Offered
Table 136. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 137. Northwest Biotherapeutics Main Business
Table 138. Northwest Biotherapeutics Latest Developments
Table 139. Glaxo Smith Kline Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. Glaxo Smith Kline Dendritic Cell Cancer Vaccine Product Offered
Table 141. Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 142. Glaxo Smith Kline Main Business
Table 143. Glaxo Smith Kline Latest Developments
Table 144. ImmunoCellular Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 145. ImmunoCellular Dendritic Cell Cancer Vaccine Product Offered
Table 146. ImmunoCellular Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 147. ImmunoCellular Main Business
Table 148. ImmunoCellular Latest Developments
Table 149. Tella Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 150. Tella Dendritic Cell Cancer Vaccine Product Offered
Table 151. Tella Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 152. Tella Main Business
Table 153. Tella Latest Developments
Table 154. Vaxil Bio Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 155. Vaxil Bio Dendritic Cell Cancer Vaccine Product Offered
Table 156. Vaxil Bio Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 157. Vaxil Bio Main Business
Table 158. Vaxil Bio Latest Developments
Table 159. Medigene Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 160. Medigene Dendritic Cell Cancer Vaccine Product Offered
Table 161. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 162. Medigene Main Business
Table 163. Medigene Latest Developments
List of Figures
Figure 1. Picture of Dendritic Cell Cancer Vaccine
Figure 2. Dendritic Cell Cancer Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dendritic Cell Cancer Vaccine Sales Growth Rate 2016-2026 (K Doses)
Figure 7. Global Dendritic Cell Cancer Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Dendritic Cell Cancer Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of CreaVax
Figure 10. Product Picture of Sipuleucel-T (Provenge)
Figure 11. Product Picture of Others
Figure 12. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020
Figure 13. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2016-2021)
Figure 14. Dendritic Cell Cancer Vaccine Consumed in Pediatrics
Figure 15. Global Dendritic Cell Cancer Vaccine Market: Pediatrics (2016-2021) & (K Doses)
Figure 16. Dendritic Cell Cancer Vaccine Consumed in Adults
Figure 17. Global Dendritic Cell Cancer Vaccine Market: Adults (2016-2021) & (K Doses)
Figure 18. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Figure 19. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application in 2020
Figure 20. Global Dendritic Cell Cancer Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Company in 2020
Figure 22. Global Dendritic Cell Cancer Vaccine Sales Market Share by Regions (2016-2021)
Figure 23. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region in 2020
Figure 24. Americas Dendritic Cell Cancer Vaccine Sales 2016-2021 (K Doses)
Figure 25. Americas Dendritic Cell Cancer Vaccine Revenue 2016-2021 ($ Millions)
Figure 26. APAC Dendritic Cell Cancer Vaccine Sales 2016-2021 (K Doses)
Figure 27. APAC Dendritic Cell Cancer Vaccine Revenue 2016-2021 ($ Millions)
Figure 28. Europe Dendritic Cell Cancer Vaccine Sales 2016-2021 (K Doses)
Figure 29. Europe Dendritic Cell Cancer Vaccine Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Dendritic Cell Cancer Vaccine Sales 2016-2021 (K Doses)
Figure 31. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue 2016-2021 ($ Millions)
Figure 32. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Country in 2020
Figure 33. Americas Dendritic Cell Cancer Vaccine Revenue Market Share by Country in 2020
Figure 34. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020
Figure 35. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2020
Figure 36. United States Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Region in 2020
Figure 41. APAC Dendritic Cell Cancer Vaccine Revenue Market Share by Regions in 2020
Figure 42. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020
Figure 43. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2020
Figure 44. China Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country in 2020
Figure 51. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country in 2020
Figure 52. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020
Figure 53. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2020
Figure 54. Germany Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2020
Figure 63. Egypt Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets